跳到正文
Molence· @MolenceBio · X·· 17 天前AI 评分32
AI 导读

12/15 🧩 Mol-1 在分子胶预测上领先,在未见靶点上优势更明显。 在 MGBench 上,Mol-1 在各分箱中均领先,且在未见靶点上优势更大: • Seen:92.2% vs 84.3% • High Homology:74.6% vs 40.7% • Low Homology:28.6% vs 19.1% #DrugDiscovery

正文 · 原文

12/15 🧩 Mol-1 leads in molecular-glue prediction with stronger margin on unseen targets.

On MGBench, Mol-1 leads across the bins with larger margin on unseen targets:
• Seen: 92.2% vs 84.3%
• High Homology: 74.6% vs 40.7%
• Low Homology: 28.6% vs 19.1%

#DrugDiscovery

来源:Molence · x.com